Division of Hematology/Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104.
Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104.
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23626-23635. doi: 10.1073/pnas.2003228117. Epub 2020 Sep 3.
Hematopoietic stem and progenitor cell (HSPC) formation and lineage differentiation involve gene expression programs orchestrated by transcription factors and epigenetic regulators. Genetic disruption of the chromatin remodeler chromodomain-helicase-DNA-binding protein 7 (CHD7) expanded phenotypic HSPCs, erythroid, and myeloid lineages in zebrafish and mouse embryos. CHD7 acts to suppress hematopoietic differentiation. Binding motifs for RUNX and other hematopoietic transcription factors are enriched at sites occupied by CHD7, and decreased RUNX1 occupancy correlated with loss of CHD7 localization. CHD7 physically interacts with RUNX1 and suppresses RUNX1-induced expansion of HSPCs during development through modulation of RUNX1 activity. Consequently, the RUNX1:CHD7 axis provides proper timing and function of HSPCs as they emerge during hematopoietic development or mature in adults, representing a distinct and evolutionarily conserved control mechanism to ensure accurate hematopoietic lineage differentiation.
造血干/祖细胞(HSPC)的形成和谱系分化涉及转录因子和表观遗传调节剂协调的基因表达程序。染色质重塑酶 chromodomain-helicase-DNA-binding protein 7(CHD7)的基因突变会扩大斑马鱼和小鼠胚胎中 HSPC、红细胞和髓系谱系的表型。CHD7 可抑制造血分化。RUNX 和其他造血转录因子的结合基序在 CHD7 占据的位点富集,RUNX1 占据的减少与 CHD7 定位的丢失相关。CHD7 与 RUNX1 相互作用,并通过调节 RUNX1 的活性来抑制发育过程中 RUNX1 诱导的 HSPC 扩增。因此,RUNX1:CHD7 轴为 HSPC 提供了适当的时机和功能,因为它们在造血发育过程中出现或在成人中成熟,代表了一种独特且进化保守的控制机制,以确保准确的造血谱系分化。